v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock And Surplus
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income
Beginning balance (in shares) at May. 26, 2024   118,900    
Beginning balance at May. 26, 2024 $ 2,242.5 $ 2,252.4 $ (35.5) $ 25.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 745.8   745.8  
Other comprehensive income (loss) 7.5     7.5
Dividends declared (497.8)   (497.8)  
Stock option exercises (in shares)   300    
Stock option exercises 29.4 $ 29.4    
Stock-based compensation 35.9 $ 35.9    
Repurchases of common stock (in shares)   (2,400)    
Repurchases of common stock (367.2) $ (46.3) (320.9)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   300    
Issuance of stock under Employee Stock Purchase Plan and other plans 9.5 $ 9.5    
Other (2.6) $ (2.6)    
Ending balance (in shares) at Feb. 23, 2025   117,100    
Ending balance at Feb. 23, 2025 2,203.0 $ 2,278.3 (108.4) 33.1
Beginning balance (in shares) at Nov. 24, 2024   117,200    
Beginning balance at Nov. 24, 2024 2,070.9 $ 2,261.0 (218.9) 28.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 323.4   323.4  
Other comprehensive income (loss) 4.3     4.3
Dividends declared (165.6)   (165.6)  
Stock option exercises (in shares)   100    
Stock option exercises 13.9 $ 13.9    
Stock-based compensation 6.0 $ 6.0    
Repurchases of common stock (in shares)   (300)    
Repurchases of common stock (53.0) $ (5.7) (47.3)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   100    
Issuance of stock under Employee Stock Purchase Plan and other plans 3.2 $ 3.2    
Other (0.1) $ (0.1)    
Ending balance (in shares) at Feb. 23, 2025   117,100    
Ending balance at Feb. 23, 2025 2,203.0 $ 2,278.3 (108.4) 33.1
Beginning balance (in shares) at May. 25, 2025   117,000    
Beginning balance at May. 25, 2025 2,311.3 $ 2,295.6 (16.1) 31.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 801.8   801.8  
Other comprehensive income (loss) (7.4)     (7.4)
Dividends declared $ (525.2)   (525.2)  
Stock option exercises (in shares) 90 100    
Stock option exercises $ 7.9 $ 7.9    
Stock-based compensation 41.5 $ 41.5    
Repurchases of common stock (in shares)   (2,700)    
Repurchases of common stock (531.5) $ (53.6) (477.9)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   300    
Issuance of stock under Employee Stock Purchase Plan and other plans 10.3 $ 10.3    
Other (4.7) $ (4.7)    
Ending balance (in shares) at Feb. 22, 2026   114,700    
Ending balance at Feb. 22, 2026 2,104.0 $ 2,297.0 (217.4) 24.4
Beginning balance (in shares) at Nov. 23, 2025   115,300    
Beginning balance at Nov. 23, 2025 2,080.4 $ 2,298.4 (235.7) 17.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net earnings 306.8   306.8  
Other comprehensive income (loss) 6.7     6.7
Dividends declared (174.2)   (174.2)  
Stock option exercises 1.9 1.9    
Stock-based compensation 7.3 $ 7.3    
Repurchases of common stock (in shares)   (700)    
Repurchases of common stock (127.2) $ (12.9) (114.3)  
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)   100    
Issuance of stock under Employee Stock Purchase Plan and other plans 3.6 $ 3.6    
Other (1.3) $ (1.3)    
Ending balance (in shares) at Feb. 22, 2026   114,700    
Ending balance at Feb. 22, 2026 $ 2,104.0 $ 2,297.0 $ (217.4) $ 24.4